Clindamycin Phosphate 1.2% and Tretinoin 0.025%
NDC 68682-300, clindamycin phosphate and tretinoin, gel, from Oceanside Pharmaceuticals.
- Product NDC
- 68682-300
- Status
- Listed
- Labeler
- Oceanside Pharmaceuticals
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA050802
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68682-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CLINDAMYCIN PHOSPHATE12 mg/g
- TRETINOIN.25 mg/g
Pharmacologic classes
Decreased Sebaceous Gland Activity [PE]; Lincosamide Antibacterial [EPC]; Lincosamides [CS]; Neuromuscular Blockade [PE]; Retinoid [EPC]; Retinoids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68682-300-30 | 68682030030 | 1 TUBE in 1 CARTON (68682-300-30) / 30 g in 1 TUBE |
| 68682-300-60 | 68682030060 | 1 TUBE in 1 CARTON (68682-300-60) / 60 g in 1 TUBE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/63b2e85d-8fe5-4f18-9e85-8492c49a7520
Use it
Look up 68682-300 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68682-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68682-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.